Entry into a Material Definitive Agreement. On August 14, 2026, HeartBeam, Inc. (the “Company”), entered into an At-The-Market Equity Offering Sales Agreement (the “Sales Agreement”) with Titan Partners Securities LLC, as sales agent, pursuant to which the Company may sell, from time to time, an aggregate of up to $25,000,000 of its common stock, par value $0.0001 per share (the “Shares”). The Shares may be issued and sold from time to time through the sales agent pursuant to the Company’s sh…

CFO — Mr. Eno: Mr. Eno departed the company and entered into a Separation Agreement.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On June 30, 2026, HeartBeam, Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for the last 30 consecutive business days, the Company is not currently in…

Chief Executive Officer — Robert P. Eno: Mr. Eno mutually agreed to depart as the Company’s Chief Executive Officer and principal executive officer.

Branislav Vajdic: Compensatory arrangements, including a performance-based restricted stock unit award and a transaction bonus agreement, were approved for Branislav Vajdic.

Entry into a Material Definitive Agreement. On April 14, 2026, HeartBeam, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Titan Partners Group LLC, a division of American Capital Partners, LLC (the “Underwriter”), pursuant to which the Company agreed to issue and sell in an underwritten public offering (the “Offering”) an aggregate of 12,500,000 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”). Th…

Board Member — Robert Eno: Robert Eno, the Company’s Chief Executive Officer, was appointed as a member of the Board.

Changes in Registrant’s Certifying Accountant Based on information provided by Marcum LLP (“Marcum”), the independent registered public accounting firm of HeartBeam, Inc. (the “Company”), CBIZ CPAs P.C. (“CBIZ CPAs”) acquired the attest business of Marcum, effective November 1, 2024. Marcum continued to serve as the Company’s independent registered public accounting firm through April 21, 2025. On April 21, 2025, Marcum resigned as the Company’s independent registered public accounting firm,…

Entry into a Material Definitive Agreement. On February 12, 2025, HeartBeam, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Public Ventures, LLC dba MDB Capital (the “Underwriter”), relating to a firm commitment underwritten offering (the “Offering”) of 5,882,353 shares (the “Shares”) of common stock of the Company, par value $0.0001 per share (“Common Stock”), at a public offering price of $1.70 per share. The Offering closed on February 14, 2…

CEO — Robert Eno: Robert Eno was promoted to Chief Executive Officer.

Chief Financial Officer — Timothy Cruickshank: The Company appointed Timothy Cruickshank as Chief Financial Officer and entered into an employment agreement with him.

Termination of a Material Definitive Agreement. In order to proceed with the PV Sales Agreement, at its sole discretion, on May 1, 2024 the Company terminated its prior Sales Agreement (the “AGP Sales Agreement”) with A.G.P./Alliance Global Partners, as sales agent (“AGP”), having provided AGP with 5 days’ written notice to terminate, in accordance with Section 11(b) of the AGP Sales Agreement.

Entry into a Material Definitive Agreement. On May 2, 2024, HeartBeam, Inc. (the “Company”) entered into a Sales Agreement (the “PV Sales Agreement”) with Public Ventures, LLC, as sales agent (“Public Ventures”), pursuant to which the Company may offer and sell (the “Offering”), from time to time, at its option, through or to Public Ventures, up to an aggregate of approximately $17,000,000 of shares of the Company’s common stock, $0.0001 par value per share (the “Shares”). Any Shares to be of…

CFO — Richard Brounstein: Richard Brounstein is retiring as CFO, but will provide advisory services to ensure a smooth transition.

Director — Michael R. Jaff: Dr. Michael R. Jaff was appointed as a director of the company, expanding the board size from seven to eight.

Director — Mark Strome, Ken Nelson: The company appointed two new directors with extensive experience in their respective fields.

ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT On May 2, 2023, HeartBeam, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ SPA ”) with an accredited investor (the “ Investo r”), for the purchase and sale in a registered direct offering of 1,000,000 shares (the “ Shares ”) of the Company’s common stock (the “ Common Stock ”) at a price of $1.50 per share, generating net proceeds from the offering of approximately $1.4 million after deducting financial advisory and legal f…

Entry Into a Material Definitive Agreement. On April 20, 2023, the Registration Statement on Form S-1 (File No. 333-269520) (the “ Registration Statement ”) relating to HeartBeam, Inc.’s (the “ Company ”) secondary offering (the “ Offering ”) of common stock (“ Common Stock ”) was declared effective by the U.S. Securities and Exchange Commission. On May 2, 2023, the Company consummated the Offering of 16,666,666 share of Common Stock at an offering price of $1.50 per share of Common Stock. Fu…

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On March 20, 2023, HeartBeam, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Stock Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing. In its annual report on Form 10-K for the period ended December…

ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT On February 28, 2023, HeartBeam, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “SPA”) with Maverick Capital Partners, LLC (the “Investor”), pursuant to which the Company agreed to sell, up to $5,000,000 (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) at 75% of the average calculated Volume Weighted Average Price per share during a Drawdown Pricing Period (as defined in the SPA).…

Chief Business Officer — Jon Hunt, Ph.D.: Dr. Jon Hunt resigned from his position as Chief Business Officer and transitioned to a Consultant role.

Entry Into A Material Definitive Agreement. On February 28, 2023, HeartBeam, Inc. (the “Company”) entered into a securities purchase agreement (the “SPA”) with Maverick Capital Partners, LLC (the “Investor”). Pursuant to the terms of the SPA, the Company agreed to sell, up to $5,000,000 (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) at 75% of the average calculated Volume Weighted Average Price (“VWAP”) per share during a Drawdown Pricing Period…

President — Robert P. Eno: Robert P. Eno was appointed as President of the Company with a comprehensive compensation package and stock options.

Changes in Registrant’s Certifying Accountant. Effective September 1, 2022, HeartBeam, Inc.’s (the “Company”) independent registered public accounting firm, Friedman LLP (“Friedman”), combined with Marcum LLP (“Marcum”). On September 19, 2022, the Audit Committee of the Board of Directors of the Company approved the dismissal of Friedman and the engagement of Marcum to serve as the independent registered public accounting firm of the Company. The services previously provided by Friedman will…

Chief Operating Officer to Operations Analyst — Alan Baumel: Mr. Baumel transitioned from Chief Operating Officer to a non-officer position of Operations Analyst due to his intention to explore part-time university teaching opportunities.